Skip to content

Group News

  • Aspen concludes strategic partnership with US-based Avion Pharmaceuticals
    on 12.11.2020

    Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius, both wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, have announced a license and commercialisation agreement with Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, for the exclusive rights to relaunch Cenestin® in the USA. This is a New Drug Application… The post Aspen […]

  • Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate
    on 02.11.2020

    Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South African subsidiaries, Pharmacare Limited (which trades as “Aspen Pharmacare”), has entered into a preliminary agreement with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the technical transfer and proposed commercial manufacture […]

  • Aspen increases revenue by 9% to R38,6 billion
    on 09.09.2020

    Johannesburg - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced reviewed provisional Group financial results for the year ended 30 June 2020. COMMENTARY RESHAPING OF THE GROUP The recently announced agreement to divest the assets related to the commercialisation of Aspen’s Thrombosis business in Europe to Mylan (refer SENS […]

  • Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary
    on 08.09.2020

    Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (“Mylan”) will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis… The […]

  • Aspen scoops prized Adam Smith Treasury Award
    on 22.07.2020

    Michael Shuttleworth, Aspen Group Treasury Executive Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam Smith 2020 Best In Class Treasury Solution In Africa Award. Gus Attridge, Aspen Group Deputy Chief Executive, shared in the good news of the award and said, “Congratulations Michael, and the whole Group Treasury team, for this well-deserved […]

Scroll To Top